Compositions for Treating Joint or Connective Tissue Disease Comprising Dextran or Poloxamer
AssigneeMedicine Park Co., Ltd
InventorsYoo Sin Park, II Hoon Lee
Life of this patent
Estimating the term…
Abstract
Disclosed is a composition for treating a joint disease or a connective tissue disease, a composition for cartilage regeneration, or a composition for treating an inflammatory disease, each of the compositions containing dextran, poloxamer or a mixture thereof. The composition stays in the joint or connective tissue for a long time due to the shock-absorbing effect, coating effect or anti-inflammation effect, relieves the shock, covers a damaged portion in a specific manner thereto, or reduces inflammation of an adhered portion. Thus, the composition may be useful for the treatment of the joint disease, the connective tissue disease, or for the cartilage regeneration.
Claims20
A pharmaceutical composition for prevention or treatment of a joint disease or a connective tissue disease, the composition comprising dextran, poloxamer or a mixture thereof as an effective ingredient.
A composition for cartilage regeneration, the composition comprising dextran, poloxamer or a mixture thereof as an effective ingredient.
A method for prevention or treatment of a joint disease or a connective tissue disease, or for cartilage regeneration, comprising administering to a patient in need thereof a composition comprising dextran, poloxamer or a mixture thereof as an active ingredient.
Dependencies are inferred from the claim text.